null Talat Bessissow, MD, MSc, FRCPC

Investigator, RI-MUHC, Montreal General Hospital site

Infectious Diseases and Immunity in Global Health Program

Associate Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

Department of Medicine, Division of Gastroenterology, MUHC



Crohn's disease • ulcerative colitis • mucosal healing • neoplasia • pathogenesis

Research Focus

My research focuses on the role of mucosal healing in the treatment of inflammatory bowel diseases. I am also looking at identifying factor that predict disease relapse.

Selected Publications

Click on Pubmed to see my current publications list

  • Kopylov U, Nemeth A, Koulaouzidis A, Makins R, Wild G, Afif W, Bitton A, Johansson GW, Bessissow T, Eliakim R, Toth E, Seidman EG. Small bowel capsule endoscopy in the management of established Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkers. Inflamm Bowel Dis. 2015 Jan;21(1):93-100. doi: 10.1097/MIB.0000000000000255. PubMed PMID: 25517597.

  • Kopylov U, Afif W, Cohen A, Bitton A, Wild G, Bessissow T, Wyse J, Al-Taweel T, Szilagyi A, Seidman E. Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease--the McGill experience. J Crohns Colitis. 2014 Nov 1;8(11):1516-22. doi: 10.1016/j.crohns.2014.06.005. Epub 2014 Jul 1. PubMed PMID: 24996483.

  • Bessissow T, Bisschops R. Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2013 Jan;7(1):57-67. doi: 10.1586/egh.12.65. Review. PubMed PMID: 23265150.

  • Bessissow T, Lemmens B, Ferrante M, Bisschops R, Van Steen K, Geboes K, Van Assche G, Vermeire S, Rutgeerts P, De Hertogh G. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol. 2012 ov;107(11):1684-92. doi: 10.1038/ajg.2012.301. Epub 2012 Nov 13. PubMed PMID: 23147523.

  • Bessissow T, Renard M, Hoffman I, Vermeire S, Rutgeerts P, Van Assche G. Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy. Aliment Pharmacol Ther. 2012 Aug;36(4):312-23. doi: 10.1111/j.1365-2036.2012.05189.x. Epub 2012 Jun 24. Review. PubMed PMID: 22725726.